The FDA granted 510(k) clearance to the SwiftNINJA steerable microcatheter for use in peripheral and coronary interventions.
Merit Medical, which manufactures the SwiftNINJA, said it would launch the catheter simultaneously with the Corvocet biopsy system on an undisclosed date. The FDA recently cleared the Covocet biopsy system, as well, according to the company.
For the third quarter of 2016, Merit Medical’s sales increased 15.3 percent to $157 million compared with the same time period last year. The company’s cardiovascular revenue during the quarter increased 15 percent to $150.6 million.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.